RecruitingNCT05142150

Palliation in Gynae-oncology: Patients Expectations and Assessment of Care (PEACE)

Palliation in Gynae-oncology: Patients Expectations and Assessment of Care


Sponsor

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Enrollment

73 participants

Start Date

Jan 12, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The overall aim is to assess the feasibility and acceptability of collecting data on the patients and carers perception of care as well as to prospectively monitor end of life care.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria8

  • A patient will be eligible for inclusion only if all of the following criteria are fulfilled:
  • Patients with any advanced gynecological malignancy and a life expectancy of approximately 4 months as estimated by their treating physician*. Potential patient groups include, but are not limited to, those with platinum-resistant/refractory recurrent epithelial ovarian cancer (PRR-EOC), metastatic/recurrent cervical or endometrial cancer progressing after platinum-based chemotherapy; high grade/undifferentiated metastatic uterine sarcoma progressing after first-line chemotherapy etc.
  • Patients may be on active cancer treatment, about to commence active cancer treatment or under observation/palliative care.
  • Age ≥ 18 years
  • Able (both physically and cognitively) to complete patient-reported outcome measures independently in languages that are available in this study (i.e. without assistance from hospital translator).
  • Age ≥ 18 years
  • A relative or close friend who is actively supporting the patient in her illness
  • Able (both physically and cognitively) to complete questionnaires independently in languages that are available in this study (i.e. without assistance from hospital translator).

Exclusion Criteria8

  • A patient will not be eligible for inclusion if any of the following criteria are fulfilled:
  • Unable to be comply with the protocol.
  • A medical or psychological condition that limits the patient´s capacity to give informed consent, such as cognitive impairment, delirium, psychosis etc.
  • Participation in another clinical trial.
  • A patient will be asked to appoint a carer.
  • A carer will not be eligible for inclusion if any of the following criteria are fulfilled:
  • Unable to be comply with the protocol
  • A medical or psychological condition that limits the carer´s capacity to give informed consent, such as cognitive impairment, delirium, psychosis etc.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuestionaire

Patient questionaires collecting data on quality of life, illness management, communication and decision making. Patient report data of end of life care ( i.e administration of chemotherapy, surgical interventions, palliative care involvement, hospital admissions) through as self reported diary. Carer for patients questionnaires their satisfaction with care. 5-7 weeks after patient deceased carer completes bereavement questionnaire and quality of death and dying.


Locations(1)

The Norwegian Radium Hospital

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05142150


Related Trials